Document Detail


Killing two birds with one stone: a chemically plausible scheme for linked nucleic acid replication and coded peptide synthesis.
MedLine Citation:
PMID:  9263634     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To understand how life began, we must explain the origins of nucleic acid replication and genetically coded peptide synthesis. Neither of these is easy to explain individually; here, we propose a chemically plausible scheme for the evolution of a process that simultaneously produced both polymers. Later, two separate machineries could have evolved from the linked process.
Authors:
J D Sutherland; J M Blackburn
Related Documents :
7248264 - Affinities of nucleic acid bases for solvent water.
9949874 - Homochirality and life.
13789984 - The inheritance of the glucose component of the phage nucleic acids.
7756154 - Allergic potential of neutrals in unmodified colophony, and a method for their separati...
16206044 - Identification of new dicaffeoylquinic acids from chrysanthemum morifolium and their an...
10353714 - Differential inhibition of ae1 and ae2 anion exchangers by oxonol dyes and by novel pol...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Chemistry & biology     Volume:  4     ISSN:  1074-5521     ISO Abbreviation:  Chem. Biol.     Publication Date:  1997 Jul 
Date Detail:
Created Date:  1997-10-01     Completed Date:  1997-10-01     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9500160     Medline TA:  Chem Biol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  481-8     Citation Subset:  IM    
Affiliation:
Dyson Perrins Laboratory, Oxford, UK. john.sutherland@dpl.ox.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
DNA Replication*
Evolution, Molecular*
RNA / biosynthesis*
Chemical
Reg. No./Substance:
63231-63-0/RNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Carboplatin and short-infusion paclitaxel in high-risk and advanced-stage ovarian carcinoma.
Next Document:  The road less travelled: taming phosphatases.